Waldenström's Macroglobulinemia clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, in progress, not accepting new patients
This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 (Zanubrutinib) vs ibrutinib in subjects with MYD88 Mutation Waldenström's Macroglobulinemia.
La Jolla, California and other locations